The Senstivity and Specificity of Using Salivary miRNAs in Detection of Malignant Transformation of Oral Lesions.

Sponsor
Cairo University (Other)
Overall Status
Completed
CT.gov ID
NCT04913545
Collaborator
(none)
18
1
14.1
1.3

Study Details

Study Description

Brief Summary

Due to cancer is a leading cause of death world wide , we will coduct the study to evaluate the diagnostic accuracy of using salivary miRNAs (412,512) from the salivary extracellular vesicles (index test) in detection of the malignant transformation of the premalignant lesions using the qualitative real time polymerase chain reaction (qRT-PCR) analysis in comparison to taking biopsy .

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: using salivary miRNA (412,512)

Detailed Description

our study is a case control study,we will coduct our study to evaluate specificity and sensitivity of using salivary extracellular vesicles miRNAs (412,512) in detection of malignant transformation in potientially malignant oral lesions by using qRT-PCR analysis ,participants will be selected and arranged in 3 groups the control group, potentially malignant group and malignant group ,the salivary samples from the participants will be collected and then microRNA extraction steps will be done through the laboratory steps ,that include extracellular vesicles isolation, PCR Analysis for miRNA-412 and miRNA-512 expression ,also the histopathologic diagnosis and examination of all specimens were confirmed by pathologist.

Study Design

Study Type:
Observational
Actual Enrollment :
18 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
The Senstivity and Specificity of Using Salivary Extracellular Vesicles as Non -Invasive Source of miRNAs (412,512) in Detection of Malignant Transformation of Potientially Malignant Oral Lesions.
Actual Study Start Date :
Jun 5, 2019
Actual Primary Completion Date :
Jan 7, 2020
Actual Study Completion Date :
Aug 7, 2020

Arms and Interventions

Arm Intervention/Treatment
normal group

participants with out any systemic medical problemes or oral lesions. we will only take saliva sample.

Diagnostic Test: using salivary miRNA (412,512)
quantitative real time polymerase chain reaction to detect the salivary miRNAs 412,512) to indicate the malignant transformation in potientially malignant oral lesions.
Other Names:
  • biopsy sample for potientially maliganat and malignant group
  • potientially malignant group

    participants with suspicious oral lesions without any medical diseases. we will take saliva sample and take a biopsy sample .

    Diagnostic Test: using salivary miRNA (412,512)
    quantitative real time polymerase chain reaction to detect the salivary miRNAs 412,512) to indicate the malignant transformation in potientially malignant oral lesions.
    Other Names:
  • biopsy sample for potientially maliganat and malignant group
  • malignant group

    participants with already diagnosed oral malignant lesions without receiving any treatment yett

    Diagnostic Test: using salivary miRNA (412,512)
    quantitative real time polymerase chain reaction to detect the salivary miRNAs 412,512) to indicate the malignant transformation in potientially malignant oral lesions.
    Other Names:
  • biopsy sample for potientially maliganat and malignant group
  • Outcome Measures

    Primary Outcome Measures

    1. the sensitivity and specificity of salivary miRNAs (412,512) to detect the malignant transformation of oral potentially malignant lesions [2 years]

      measuring the sensitivity and specificity of using the salivary miRNAs(412,512)to detect the malignant transformation in potentially malignant lesions

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    35 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Clinically evident lesions as morphologically altered tissue noted at conventional visual tactile examination

    • Clinically evident suspicious lesions which are morphologically altered tissue noted at comprehensive visual ductile examination ( CVTE) with a definitive diagnosis of a potentially malignant disorders (PMD) or even a malignant disorder to be a distinct possibly.

    • Healthy subjects presenting no clinically detectable oral lesions matched for age, gender, and risk factors will recruited as controls.

    Exclusion Criteria:

    .<18 years of age.

    • pregnant or breast feeding. .psychiatrically or mentally unstable.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Dentistry Cairo Egypt

    Sponsors and Collaborators

    • Cairo University

    Investigators

    • Principal Investigator: Ghareeb, Assistant lecturer

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Neveen Nabil Ghareeb, assistant lecturer in MSA university, Cairo University
    ClinicalTrials.gov Identifier:
    NCT04913545
    Other Study ID Numbers:
    • 19 September,2018 ,Version 2
    First Posted:
    Jun 4, 2021
    Last Update Posted:
    Jun 9, 2021
    Last Verified:
    Jun 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 9, 2021